The response to repeated nitric oxide inhalation is inconsistent in patients with acute respiratory distress syndrome

Anesthesiology

Volumn 88, Issue 3, 1998, Pages 634-641

  Treggiari Venzi, Miriam ^b   Ricou, Bara ^b   Romand, Jacques André ^b   Suter, Peter M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

Acute lung injury; Human endothelium derived relaxing factor; Hypoxia; Lung; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HEMODYNAMICS; HUMAN; HYPOXEMIA; INHALATIONAL DRUG ADMINISTRATION; LUNG GAS EXCHANGE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ACUTE DISEASE; ADULT; AGED; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFANT, NEWBORN; LUNG; MALE; MIDDLE AGED; NITRIC OXIDE; OXYGEN; PULMONARY GAS EXCHANGE; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0031886944     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199803000-00013     Document Type: Article

References (35)

1. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-6
2. Ignarro LJ: Biological actions and properties of endothelium derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65:1-21
3. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J: Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991; 338:1173-4
4. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM: Inhaled nitric oxide for the adult respiratory distress syndrome. N Eogl J Med 1993; 328:399-405
5. Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD, Zapol WM: Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. ANESTHESIOLOGY 1994; 80:761-70
6. Rossaint R, Gerlach H, Schmidt-Ruhnke H, Pappert D, Lewan- dowsky K, Stuedel W, Falke K: Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 1995; 197:1107-15
7. Ricou B, Suter PM. Variable effects of nitric oxide (NO) in ARDS patients. Am Rev Respir Dis 1993; 147:A350
8. Krafft P, Friedrich P, Fitzgerald RD, Koc D, Steltzer H: Effectiveness of nitric oxide inhalation in septic ARDS. Chest 1996; 109:486-93
9. Barberà JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R: Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996; 347:436-40
10. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Le Gall JR, Morris A, Spragg RA, and the Consensus Committee: The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-24
11. Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-3
12. Suter PM, Fairley HB, Isenberg MD: Optimum end-expiratory airway pressure in patients with acute pulmonary failure. N Engl J Med 1975; 292:284-9
13. Levy LS, Lemeshow S: Sampling Populations, 2nd ed. New York, NY, Wiley, 1991
14. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Amer TG: Epi Info, version 6: A word processing database, and statistics program for epidemiology on microcomputers. Atlanta, GA, Centers for Disease Control and Prevention, 1994
15. Dellinger RP, Zimmerman JL, Hyers TM, Taylor RW, Straube RC, Hauser DL, Damask MC, Davis K Jr, Criner GJ: Inhaled nitric oxide in ARDS: preliminary results of a multicenter clinical trial. Grit Care Med 1996; 24:A29
16. Puybasset L, Rouby J-J, Mourgeon E, Cluzel P, Souhil Z, Law-Koune J-D, Stewart T, Devilliers C, Lu Q, Roche S, Kaflon P, Vicaut E, Viars P: Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Respir Crit Care Med 1995; 152:318-28
17. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newbom. Lancet 1992; 340:819-20
18. Roberts JD, Lang P, Bigatello LM, Vlahakes GE, Zapol WM: Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87:447-53
19. Wessel DL, Adatia I, Giglia TM, Thompson JM, Kulik TJ: Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardlopulmonary bypass. Circulation 1993; 88:218-38
20. Girard C, Lehot JJ, Pannetier JC, Filley S, French P, Estanove S: Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. ANESTHESIOLOGY 1992; 77:880-3
21. McMahon TJ, Ignarro LHJ, Kadowitz PJ: Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J Appl Physiol 1993; 74:1704-11
22. Cremona G, Higenbottam TW, Dinh-Xuan AT: Inhibitors of endothelium derived relaxing factor increase pulmonary vascular resistance in isolated perfused human lungs. Eur Respir J 1991; 4:336
23. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabriet PE: Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 1991; 87:155-62
24. Romand JA, Pinsky MR, Firestone L, Zar HA, Lancaster JR: Inhaled nitric oxide partially reverses hypoxic pulmonary vasoconstriction in the dog. J Appl Physiol 1994; 76:1350-5
25. Romand JA, Pinsky MR, Firestone L, Zar HA, Lancaster JR: Effect of inhaled nitric oxide on pulmonary haemodynamics after acute lung injury in dogs. J Appl Physiol 1994; 76:1356-62
26. Chollet-Martin S, Gatecel C, Kermarrec N, Gougerot-Pocidalo MA, Payen DM: Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med 1996; 153:985-90
27. Voelkel NF: Mechanisms of hypoxic pulmonary vasoconstriction. Am Rev Respir Dis 1986; 133:1186-95
28. Gerlach H, Rossaint R, Pappert D, Falke KJ: Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin invest 1993; 23:499-502
29. 1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. ANESTHESIOLOGY 1989; 70:601-6
30. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J: Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 889:7674-7
31. Stamler JS, Singel DJ, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science 1992; 258:1898-902
32. Li-Jia, Bonaventura C, Bonaventura J, Stamler J: S-nitrosohemoglobin: A dynamic activity of blood involved in vascular control. Nature 1996; 380:221-6
33. Nagao T, Illiano S, Vanhoutte PM: Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats. Am J Physiol 1992; 263(H32):1090-4
34. Montgomery AB, Stager MA, Carrico CJ, Hudson LD: Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132:485-9
35. Sydow M, Bristow F, Zinserling J, Allen SJ: Variation of nitricoxide concentration during inspiration. Crit Care Med 1997; 25:365-71